▶ 調査レポート

卵巣癌遺伝子治療の世界市場:市場規模・現状・予測

• 英文タイトル:Global Gene Therapy for Ovarian Cancer Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。卵巣癌遺伝子治療の世界市場:市場規模・現状・予測 / Global Gene Therapy for Ovarian Cancer Market Size, Status and Forecast 2019-2025 / QYR9ST03895資料のイメージです。• レポートコード:QYR9ST03895
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、93ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、卵巣癌遺伝子治療の世界市場について調査・分析し、卵巣癌遺伝子治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(静脈内、腫瘍内、腹腔内)、用途別(卵巣癌(不特定)、再発性卵巣上皮癌、プラチナ耐性卵巣癌)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の卵巣癌遺伝子治療市場動向
・主要企業別マーケットシェア
・卵巣癌遺伝子治療の種類別市場規模2014-2019
(静脈内、腫瘍内、腹腔内)
・卵巣癌遺伝子治療の用途別市場規模2014-2019
(卵巣癌(不特定)、再発性卵巣上皮癌、プラチナ耐性卵巣癌)
・卵巣癌遺伝子治療の北米市場:主要企業・種類別/用途別市場規模
・卵巣癌遺伝子治療のヨーロッパ市場:主要企業・種類別/用途別市場規模
・卵巣癌遺伝子治療の中国市場:主要企業・種類別/用途別市場規模
・卵巣癌遺伝子治療の日本国内市場:主要企業・種類別/用途別市場規模
・卵巣癌遺伝子治療の東南アジア市場:主要企業・種類別/用途別市場規模
・卵巣癌遺伝子治療のインド市場:主要企業・種類別/用途別市場規模
・卵巣癌遺伝子治療の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Takara Bio、VBL Therapeutics、CELSION、Targovax)
・卵巣癌遺伝子治療の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor, and stromal ovarian tumor are some of the less common types. It is the seventh most common cancer in women globally and 18th most common cancer overall. The ovarian cancer immunotherapies market has already got some commercially successful chemotherapy products. However, chemotherapy often involves a combination of two or more drugs, given intravenously every 3-4 weeks, and mostly associated with long-lasting side/adverse effects. Various studies have shown that chemotherapy can damage the blood-producing cells of the bone marrow, resulting in blood-related complications.Gene therapy is expected to be one of the next big paradigm shift in pharmacology due to the extensive on-going research studies, both at academic and industry level. Gene therapy is one of the most exciting approaches for the treatment of ovarian cancer. Replacement gene therapy is gaining attention as it has the potential to cure ovarian cancer and can be used as a promising option for long-lasting treatment.
In 2018, the global Gene Therapy for Ovarian Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gene Therapy for Ovarian Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Therapy for Ovarian Cancer development in United States, Europe and China.

The key players covered in this study
Takara Bio
VBL Therapeutics
CELSION
Targovax

Market segment by Type, the product can be split into
Intravenous
Intratumoral
Intraperitoneal

Market segment by Application, split into
Ovarian Cancer (unspecified)
Recurrent Ovarian Epithelial Cancer
Platinum-Resistant Ovarian Cancer

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gene Therapy for Ovarian Cancer status, future forecast, growth opportunity, key market and key players.
To present the Gene Therapy for Ovarian Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gene Therapy for Ovarian Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type (2014-2025)
1.4.2 Intravenous
1.4.3 Intratumoral
1.4.4 Intraperitoneal
1.5 Market by Application
1.5.1 Global Gene Therapy for Ovarian Cancer Market Share by Application (2014-2025)
1.5.2 Ovarian Cancer (unspecified)
1.5.3 Recurrent Ovarian Epithelial Cancer
1.5.4 Platinum-Resistant Ovarian Cancer
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gene Therapy for Ovarian Cancer Market Size
2.2 Gene Therapy for Ovarian Cancer Growth Trends by Regions
2.2.1 Gene Therapy for Ovarian Cancer Market Size by Regions (2014-2025)
2.2.2 Gene Therapy for Ovarian Cancer Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Gene Therapy for Ovarian Cancer Market Size by Manufacturers
3.1.1 Global Gene Therapy for Ovarian Cancer Revenue by Manufacturers (2014-2019)
3.1.2 Global Gene Therapy for Ovarian Cancer Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Gene Therapy for Ovarian Cancer Key Players Head office and Area Served
3.3 Key Players Gene Therapy for Ovarian Cancer Product/Solution/Service
3.4 Date of Enter into Gene Therapy for Ovarian Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gene Therapy for Ovarian Cancer Market Size by Type (2014-2019)
4.2 Global Gene Therapy for Ovarian Cancer Market Size by Application (2014-2019)

5 United States
5.1 United States Gene Therapy for Ovarian Cancer Market Size (2014-2019)
5.2 Gene Therapy for Ovarian Cancer Key Players in United States
5.3 United States Gene Therapy for Ovarian Cancer Market Size by Type
5.4 United States Gene Therapy for Ovarian Cancer Market Size by Application

6 Europe
6.1 Europe Gene Therapy for Ovarian Cancer Market Size (2014-2019)
6.2 Gene Therapy for Ovarian Cancer Key Players in Europe
6.3 Europe Gene Therapy for Ovarian Cancer Market Size by Type
6.4 Europe Gene Therapy for Ovarian Cancer Market Size by Application

7 China
7.1 China Gene Therapy for Ovarian Cancer Market Size (2014-2019)
7.2 Gene Therapy for Ovarian Cancer Key Players in China
7.3 China Gene Therapy for Ovarian Cancer Market Size by Type
7.4 China Gene Therapy for Ovarian Cancer Market Size by Application

8 Japan
8.1 Japan Gene Therapy for Ovarian Cancer Market Size (2014-2019)
8.2 Gene Therapy for Ovarian Cancer Key Players in Japan
8.3 Japan Gene Therapy for Ovarian Cancer Market Size by Type
8.4 Japan Gene Therapy for Ovarian Cancer Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Gene Therapy for Ovarian Cancer Market Size (2014-2019)
9.2 Gene Therapy for Ovarian Cancer Key Players in Southeast Asia
9.3 Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Type
9.4 Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Application

10 India
10.1 India Gene Therapy for Ovarian Cancer Market Size (2014-2019)
10.2 Gene Therapy for Ovarian Cancer Key Players in India
10.3 India Gene Therapy for Ovarian Cancer Market Size by Type
10.4 India Gene Therapy for Ovarian Cancer Market Size by Application

11 Central & South America
11.1 Central & South America Gene Therapy for Ovarian Cancer Market Size (2014-2019)
11.2 Gene Therapy for Ovarian Cancer Key Players in Central & South America
11.3 Central & South America Gene Therapy for Ovarian Cancer Market Size by Type
11.4 Central & South America Gene Therapy for Ovarian Cancer Market Size by Application

12 International Players Profiles
12.1 Takara Bio
12.1.1 Takara Bio Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gene Therapy for Ovarian Cancer Introduction
12.1.4 Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2014-2019)
12.1.5 Takara Bio Recent Development
12.2 VBL Therapeutics
12.2.1 VBL Therapeutics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gene Therapy for Ovarian Cancer Introduction
12.2.4 VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2014-2019)
12.2.5 VBL Therapeutics Recent Development
12.3 CELSION
12.3.1 CELSION Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gene Therapy for Ovarian Cancer Introduction
12.3.4 CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2014-2019)
12.3.5 CELSION Recent Development
12.4 Targovax
12.4.1 Targovax Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gene Therapy for Ovarian Cancer Introduction
12.4.4 Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2014-2019)
12.4.5 Targovax Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Gene Therapy for Ovarian Cancer Key Market Segments
Table Key Players Gene Therapy for Ovarian Cancer Covered
Table Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Gene Therapy for Ovarian Cancer Market Size Market Share by Type 2014-2025
Figure Intravenous Figures
Table Key Players of Intravenous
Figure Intratumoral Figures
Table Key Players of Intratumoral
Figure Intraperitoneal Figures
Table Key Players of Intraperitoneal
Table Global Gene Therapy for Ovarian Cancer Market Size Growth by Application 2014-2025 (Million US$)
Figure Ovarian Cancer (unspecified) Case Studies
Figure Recurrent Ovarian Epithelial Cancer Case Studies
Figure Platinum-Resistant Ovarian Cancer Case Studies
Figure Gene Therapy for Ovarian Cancer Report Years Considered
Table Global Gene Therapy for Ovarian Cancer Market Size 2014-2025 (Million US$)
Figure Global Gene Therapy for Ovarian Cancer Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gene Therapy for Ovarian Cancer Market Size by Regions 2014-2025 (Million US$)
Table Global Gene Therapy for Ovarian Cancer Market Size by Regions 2014-2019 (Million US$)
Table Global Gene Therapy for Ovarian Cancer Market Share by Regions 2014-2019
Figure Global Gene Therapy for Ovarian Cancer Market Share by Regions 2014-2019
Figure Global Gene Therapy for Ovarian Cancer Market Share by Regions 2019
Table Market Top Trends
Table Global Gene Therapy for Ovarian Cancer Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Gene Therapy for Ovarian Cancer Market Share by Manufacturers (2014-2019)
Figure Global Gene Therapy for Ovarian Cancer Market Share by Manufacturers in 2018
Table Global Gene Therapy for Ovarian Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gene Therapy for Ovarian Cancer Product/Solution/Service
Table Date of Enter into Gene Therapy for Ovarian Cancer Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gene Therapy for Ovarian Cancer Market Size by Type (2014-2019) (Million US$)
Table Global Gene Therapy for Ovarian Cancer Market Size Share by Type (2014-2019)
Figure Global Gene Therapy for Ovarian Cancer Market Size Market Share by Type (2014-2019)
Table Global Gene Therapy for Ovarian Cancer Market Size by Application (2014-2019) (Million US$)
Table Global Gene Therapy for Ovarian Cancer Market Size Share by Application (2014-2019)
Figure Global Gene Therapy for Ovarian Cancer Market Size Market Share by Application (2014-2019)
Figure Global Gene Therapy for Ovarian Cancer Revenue Market Share by Application in 2018
Figure United States Gene Therapy for Ovarian Cancer Market Size 2014-2019 (Million US$)
Table United States Key Players Gene Therapy for Ovarian Cancer Revenue (2018-2019) (Million US$)
Table United States Key Players Gene Therapy for Ovarian Cancer Market Share (2018-2019)
Table United States Gene Therapy for Ovarian Cancer Market Size by Type (2014-2019) (Million US$)
Table United States Gene Therapy for Ovarian Cancer Market Share by Type (2014-2019)
Table United States Gene Therapy for Ovarian Cancer Market Size by Application (2014-2019) (Million US$)
Table United States Gene Therapy for Ovarian Cancer Market Share by Application (2014-2019)
Figure Europe Gene Therapy for Ovarian Cancer Market Size 2014-2019 (Million US$)
Table Europe Key Players Gene Therapy for Ovarian Cancer Revenue (2018-2019) (Million US$)
Table Europe Key Players Gene Therapy for Ovarian Cancer Market Share (2018-2019)
Table Europe Gene Therapy for Ovarian Cancer Market Size by Type (2014-2019) (Million US$)
Table Europe Gene Therapy for Ovarian Cancer Market Share by Type (2014-2019)
Table Europe Gene Therapy for Ovarian Cancer Market Size by Application (2014-2019) (Million US$)
Table Europe Gene Therapy for Ovarian Cancer Market Share by Application (2014-2019)
Figure China Gene Therapy for Ovarian Cancer Market Size 2014-2019 (Million US$)
Table China Key Players Gene Therapy for Ovarian Cancer Revenue (2018-2019) (Million US$)
Table China Key Players Gene Therapy for Ovarian Cancer Market Share (2018-2019)
Table China Gene Therapy for Ovarian Cancer Market Size by Type (2014-20189) (Million US$)
Table China Gene Therapy for Ovarian Cancer Market Share by Type (2014-2019)
Table China Gene Therapy for Ovarian Cancer Market Size by Application (2014-2019) (Million US$)
Table China Gene Therapy for Ovarian Cancer Market Share by Application (2014-2019)
Figure Japan Gene Therapy for Ovarian Cancer Market Size 2014-2019 (Million US$)
Table Japan Key Players Gene Therapy for Ovarian Cancer Revenue (2018-2019) (Million US$)
Table Japan Key Players Gene Therapy for Ovarian Cancer Market Share (2018-2019)
Table Japan Gene Therapy for Ovarian Cancer Market Size by Type (2014-2019) (Million US$)
Table Japan Gene Therapy for Ovarian Cancer Market Share by Type (2014-2019)
Table Japan Gene Therapy for Ovarian Cancer Market Size by Application (2014-2019) (Million US$)
Table Japan Gene Therapy for Ovarian Cancer Market Share by Application (2014-2019)
Figure Southeast Asia Gene Therapy for Ovarian Cancer Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gene Therapy for Ovarian Cancer Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gene Therapy for Ovarian Cancer Market Share (2018-2019)
Table Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Gene Therapy for Ovarian Cancer Market Share by Type (2014-2019)
Table Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Gene Therapy for Ovarian Cancer Market Share by Application (2014-2019)
Figure India Gene Therapy for Ovarian Cancer Market Size 2014-2019 (Million US$)
Table India Key Players Gene Therapy for Ovarian Cancer Revenue (2018-2019) (Million US$)
Table India Key Players Gene Therapy for Ovarian Cancer Market Share (2018-2019)
Table India Gene Therapy for Ovarian Cancer Market Size by Type (2014-2019) (Million US$)
Table India Gene Therapy for Ovarian Cancer Market Share by Type (2014-2019)
Table India Gene Therapy for Ovarian Cancer Market Size by Application (2014-2019) (Million US$)
Table India Gene Therapy for Ovarian Cancer Market Share by Application (2014-2019)
Figure Central & South America Gene Therapy for Ovarian Cancer Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gene Therapy for Ovarian Cancer Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gene Therapy for Ovarian Cancer Market Share (2018-2019)
Table Central & South America Gene Therapy for Ovarian Cancer Market Size by Type (2014-2019) (Million US$)
Table Central & South America Gene Therapy for Ovarian Cancer Market Share by Type (2014-2019)
Table Central & South America Gene Therapy for Ovarian Cancer Market Size by Application (2014-2019) (Million US$)
Table Central & South America Gene Therapy for Ovarian Cancer Market Share by Application (2014-2019)
Table Takara Bio Company Details
Table Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2014-2019) (Million US$)
Figure Takara Bio Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2014-2019)
Table Takara Bio Recent Development
Table VBL Therapeutics Company Details
Table VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2014-2019)(Million US$)
Figure VBL Therapeutics Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2014-2019)
Table VBL Therapeutics Recent Development
Table CELSION Company Details
Table CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2014-2019)(Million US$)
Figure CELSION Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2014-2019)
Table CELSION Recent Development
Table Targovax Company Details
Table Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2014-2019)(Million US$)
Figure Targovax Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2014-2019)
Table Targovax Recent Development
Table Global Gene Therapy for Ovarian Cancer Market Size by Regions (Million US$) 2019-2025
Figure Global Gene Therapy for Ovarian Cancer Market Size Share by Regions (2019-2025)
Figure Global Gene Therapy for Ovarian Cancer Market Size Share by Regions in 2025
Figure United States Gene Therapy for Ovarian Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gene Therapy for Ovarian Cancer Market Size Forecast (2019-2025)(Million USD)
Figure China Gene Therapy for Ovarian Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gene Therapy for Ovarian Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gene Therapy for Ovarian Cancer Market Size Forecast (2019-2025)(Million USD)
Figure India Gene Therapy for Ovarian Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gene Therapy for Ovarian Cancer Market Size Forecast (2019-2025)(Million USD)
Table Global Gene Therapy for Ovarian Cancer Market Size by Product (2019-2025) (Million US$)
Figure Global Gene Therapy for Ovarian Cancer Market Size by Product (2019-2025)
Figure Global Gene Therapy for Ovarian Cancer Market Size by Product in 2025
Table Global Gene Therapy for Ovarian Cancer Market Size by Application (2019-2025) (Million US$)
Figure Global Gene Therapy for Ovarian Cancer Market Size by Application (2019-2025)
Figure Global Gene Therapy for Ovarian Cancer Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources